Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
Now available on-demand! Cracking the code: learnings from oligonucleotide method development WATCH NOW

Infographic: HRMS in DMPK

28 Nov 2019
General interest

As part of our Spotlight on HRMS, we carried out a survey to gain an insight into the trends, challenges and developments associated with the use of HRMS for DMPK studies. We would like to thank everyone who was able to share their thoughts by taking part in the survey – you can see the results below in our infographic.

HRMS in DMPK spotlight infographic_NM-01-min

< Back to – Spotlight: HRMS in DMPK

Top content

  • Novel blood testing technology for Alzheimer’s Bio-Hermes-002 study
  • Deeper than the definition: ADCs, UHPLC and superficially porous particle technology
  • Tracking brain injury after stroke

Related tags

DMPK HRMS infographic QQQ Survey
Previous article Next article

Related articles

14 APR 2020 BIOMARKERS
Biomarker discovery survey
8 JUN 2011 CHROMATOGRAPHY
High-resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures
7 JAN 2016 DRUG DEVELOPMENT
Christopher Beaver details his thoughts on the recent biomarker (and biosensors) Spotlight survey and the consensus of APPS Workshop on Crystal City VI: BMV for Biomarkers
6 JUL 2016 MS (LC–MS/MS, HRMS, IMS)
10th WRIB Poster Award winner: Yang Xu
3 AUG 2016 GENERAL INTEREST
Quantitation of high resolution MS data using UNIFI (Waters Corporation)
16 SEP 2021 MS (LC–MS/MS, HRMS, IMS)
eBook: High-resolution mass spectrometry
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone